摘要
目的:评价氟比洛芬酯联合芬太尼透皮贴剂治疗难治性癌痛的疗效。方法:100例难治性癌痛患者随机分为3组,分别为氟比洛芬酯组(33例)、芬太尼组(33例)和联合用药组(34组),观察止痛效果和毒副反应。结果:氟比洛芬酯、芬太尼组和联合用药组的癌痛缓解率分别为72.7%、69.7%和91.2%,均无明显的毒副反应。结论:氟比洛芬酯联合芬太尼透皮贴剂是治疗难治性癌痛的优选方案。
Objective： To evaluate the analgesic effect of flurbiprofen axetil and transdermal fentanyl on refractory cancer pain.Methods： One hundred patients with refractory cancer pain were divided into three groups randomly.Thirty-three patients received only flurbiprofen axetil,33 patients received only transdermal fentanyl,and the other 34 patients received the combined therapy.The analgesic effects and side effects were observed respectively.Results： The pain control rates of flurbiprofen axetil group,transdermal fentanyl group and the combined therapy group were 72.7%,69.7%,and 91.2%,respectively.No obvious side effects were found in all the three groups.Conclusion： Flurbiprofen axetil combined with transdermal fentanyl is an optimized treatment for refractory cancer pain.
出处
《武汉大学学报（医学版）》
CAS
北大核心
2012年第4期582-584,共3页
Medical Journal of Wuhan University
关键词
氟比洛芬酯
芬太尼
癌痛
Flurbiprofen Axetil
Transdermal Fentanyl
Cancer Pain
